Companies are telling their investors how President Donald Trump’s plan to radically remake the US government poses new risks ...

For the second year running, nonprofit consulting firm Good Energy applied its Climate Reality Check to the actual Oscar-nominated films. Intended as a climate version of the Bechdel test, which ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

Valentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim ...

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...